Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07361367

A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants

A Phase 1 Study to Evaluate the Pharmacokinetics of a Tablet Formulation of ABBV-722 and the Effect of Food on Its Bioavailability in Healthy Adult Subjects

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
11 (actual)
Sponsor
AbbVie · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to evaluate the PK of a tablet formulation of ABBV-722 under fasted conditions and the effect of food on its bioavailability after administration of single doses

Conditions

Interventions

TypeNameDescription
DRUGABBV-722Oral Tablet

Timeline

Start date
2026-01-15
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2026-01-23
Last updated
2026-02-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07361367. Inclusion in this directory is not an endorsement.